drugset
drugset / Trial / NCT00102154

An Investigational Drug Study in Healthy Adult Volunteers in a Model of Insomnia (0928-007)

NCT00102154 ↗

Phase 3 Withdrawn H. Lundbeck A/S
RandomizedParallel-groupDouble-blindTreatment

Summary

A study to evaluate the safety and effectiveness of an investigational drug for insomnia (a sleep disorder).

Timeline

Start
2005-01
Primary completion
—
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject gaboxadol Small molecule — —

Indications

insomnia